Skip to main content

. 1978 Apr 29;1(6120):1113–1114. doi: 10.1136/bmj.1.6120.1113

Sodium nitroprusside in idiopathic respiratory distress syndrome.

T R Abbott, G J Rews, D Dickinson, G Reynolds, D Lord

PMCID: PMC1604286 PMID: 25114

1113

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bennett N. R., Abbott T. R. The use of sodium nitroprusside in children. Anaesthesia. 1977 May;32(5):456–463. doi: 10.1111/j.1365-2044.1977.tb09983.x. [DOI] [PubMed] [Google Scholar]
Chu J., Clements J. A., Cotton E. K., Klaus M. H., Sweet A. Y., Tooley W. H., Bradley B. L., Brandorff L. C. Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics. 1967 Oct;40(4 Suppl):709–782. [PubMed] [Google Scholar]
Rowe G. G., Henderson R. H. Systemic and coronary hemodynamic effects of sodium nitroprusside. Am Heart J. 1974 Jan;87(1):83–87. doi: 10.1016/0002-8703(74)90394-9. [DOI] [PubMed] [Google Scholar]
Yamada K., Shirahata A., Meguro T. The effects of an alpha blocking agent on the respiratory distress syndrome with disseminated intravascular coagulation in the newborn infants and experimental animals. Thromb Res. 1976 May;8(2 Suppl):179–188. doi: 10.1016/0049-3848(76)90061-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES